Meijuan Tu

Title(s)Associate Scientist, Biochemistry and Molecular Medicine
SchoolSchool of Medicine
Address2700 STOCKTON BLVD., SUIT 2120B
CA 95817
Phone916-734-4848
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. An Iterative Approach to Polish the Nanopore Sequencing Basecalling for Therapeutic RNA Quality Control. bioRxiv. 2024 Sep 18. Wang Z, Tu MJ, Liu Z, Wang KK, Fang Y, Hao N, Zhang HH, Que J, Sun X, Yu AM, Ding H. PMID: 39345479; PMCID: PMC11429612.
      View in: PubMed   Mentions:
    2. The Precise Basecalling of Short-Read Nanopore Sequencing. bioRxiv. 2024 Sep 17. Wang Z, Tu MJ, Song C, Liu Z, Wang KK, Chen S, Yu AM, Ding H. PMID: 39345391; PMCID: PMC11429927.
      View in: PubMed   Mentions:
    3. Efficacy and safety of avatrombopag in the treatment of thrombocytopenia after umbilical cord blood transplantation. Chin Med J (Engl). 2024 Sep 10. Huang A, Sun G, Tang B, Han Y, Wan X, Yao W, Song K, Cheng Y, Wu W, Tu M, Wu Y, Pan T, Zhu X. PMID: 39252155.
      View in: PubMed   Mentions:    Fields:    
    4. Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs. Front Pharmacol. 2024; 15:1423416. Wang Y, Tu MJ, Yu AM. PMID: 39114355; PMCID: PMC11303158.
      View in: PubMed   Mentions:
    5. Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents. RNA. 2024 May 16; 30(6):680-694. Traber GM, Yi C, Batra N, Tu MJ, Yu AM. PMID: 38429100; PMCID: PMC11098458.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    6. Molecular Engineering of Functional SiRNA Agents. ACS Synth Biol. 2024 Jun 21; 13(6):1906-1915. Batra N, Tu MJ, Yu AM. PMID: 38733599; PMCID: PMC11197084.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    7. Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer. Acta Pharm Sin B. 2023 Oct; 13(10):4273-4290. Chen Y, Tu MJ, Han F, Liu Z, Batra N, Lara PN, Chen HW, Bi H, Yu AM. PMID: 37799388; PMCID: PMC10547963.
      View in: PubMed   Mentions: 3  
    8. Erratum: Author correction to 'Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo' [Acta Pharmaceutica Sinica B 11 (2021) 3950-3965]. Acta Pharm Sin B. 2023 Aug; 13(8):3577-3578. Deng L, Petrek H, Tu MJ, Batra N, Yu AX, Yu AM. PMID: 37655312; PMCID: PMC10465936.
      View in: PubMed   Mentions:
    9. Recent Advances in Novel Recombinant RNAs for Studying Post-transcriptional Gene Regulation in Drug Metabolism and Disposition. Curr Drug Metab. 2023; 24(3):175-189. Tu MJ, Yu AM. PMID: 37170982; PMCID: PMC10825985.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. ATR Inhibition in Advanced Urothelial Carcinoma. Clin Genitourin Cancer. 2023 04; 21(2):203-207. Leibrandt RC, Tu MJ, Yu AM, Lara PN, Parikh M. PMID: 36604210; PMCID: PMC10750798.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions. Bioengineered. 2022 05; 13(5):12489-12503. Yi WR, Tu MJ, Yu AX, Lin J, Yu AM. PMID: 35579419; PMCID: PMC9276019.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    12. Bioengineered RNA Therapy in Patient-Derived Organoids and Xenograft Mouse Models. Methods Mol Biol. 2022; 2521:191-206. Tu MJ, Yi CM, Traber GM, Yu AM. PMID: 35732999; PMCID: PMC9484490.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    13. Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo. Acta Pharm Sin B. 2021 Dec; 11(12):3950-3965. Deng L, Petrek H, Tu MJ, Batra N, Yu AX, Yu AM. PMID: 35024318; PMCID: PMC8727917.
      View in: PubMed   Mentions: 14  
    14. Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination. Pharmacol Ther. 2022 02; 230:107967. Yu AM, Tu MJ. PMID: 34403681; PMCID: PMC9477512.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCellsPHPublic Health
    15. A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism. J Pharmacol Exp Ther. 2021 Jun; 377(3):305-315. Choi YH, Zhang C, Liu Z, Tu MJ, Yu AX, Yu AM. PMID: 33712506; PMCID: PMC8140393.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    16. In vivo fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapy. Theranostics. 2021; 11(10):4858-4871. Li PC, Tu MJ, Ho PY, Batra N, Tran MML, Qiu JX, Wun T, Lara PN, Hu X, Yu AX, Yu AM. PMID: 33754032; PMCID: PMC7978307.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    17. Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growth. Biochem Pharmacol. 2021 07; 189:114392. Petrek H, Yan Ho P, Batra N, Tu MJ, Zhang Q, Qiu JX, Yu AM. PMID: 33359565; PMCID: PMC8187260.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    18. Expression and Purification of tRNA/ pre-miRNA-Based Recombinant Noncoding RNAs. Methods Mol Biol. 2021; 2323:249-265. Tu MJ, Wright HK, Batra N, Yu AM. PMID: 34086286; PMCID: PMC9516694.
      View in: PubMed   Mentions: 6     Fields:    Translation:CellsPHPublic Health
    19. MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis. Mol Pharmacol. 2020 12; 98(6):686-694. Tu MJ, Duan Z, Liu Z, Zhang C, Bold RJ, Gonzalez FJ, Kim EJ, Yu AM. PMID: 33051382; PMCID: PMC7673485.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    20. Pharmacokinetic and Pharmacodynamic Factors Contribute to Synergism between Let-7c-5p and 5-Fluorouracil in Inhibiting Hepatocellular Carcinoma Cell Viability. Drug Metab Dispos. 2020 12; 48(12):1257-1263. Jilek JL, Tu MJ, Zhang C, Yu AM. PMID: 33051247; PMCID: PMC7684025.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    21. RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges. Pharmacol Rev. 2020 10; 72(4):862-898. Yu AM, Choi YH, Tu MJ. PMID: 32929000; PMCID: PMC7495341.
      View in: PubMed   Mentions: 130     Fields:    Translation:HumansCellsPHPublic Health
    22. A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis. Theranostics. 2020; 10(16):7193-7210. Chen Y, Zhou Y, Han F, Zhao Y, Tu M, Wang Y, Huang C, Fan S, Chen P, Yao X, Guan L, Yu AM, Gonzalez FJ, Huang M, Bi H. PMID: 32641987; PMCID: PMC7330864.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    23. The Optimal Outcome of Suppressing Ewing Sarcoma Growth in vivo With Biocompatible Bioengineered miR-34a-5p Prodrug. Front Oncol. 2020; 10:222. Li DF, Yuan Y, Tu MJ, Hu X, Li YZ, Yi WR, Li PC, Zhao Y, Cheng Z, Yu AM, Jian C, Yu AX. PMID: 32161722; PMCID: PMC7052494.
      View in: PubMed   Mentions: 1  
    24. Novel approaches for efficient  in vivo fermentation production of noncoding RNAs. Appl Microbiol Biotechnol. 2020 Mar; 104(5):1927-1937. Yu AM, Batra N, Tu MJ, Sweeney C. PMID: 31953559; PMCID: PMC7385725.
      View in: PubMed   Mentions: 16     Fields:    Translation:Cells
    25. Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics. Acta Pharm Sin B. 2020 Jan; 10(1):159-170. Yi W, Tu MJ, Liu Z, Zhang C, Batra N, Yu AX, Yu AM. PMID: 31993313; PMCID: PMC6976971.
      View in: PubMed   Mentions: 33  
    26. Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs. Appl Microbiol Biotechnol. 2019 Aug; 103(15):6107-6117. Petrek H, Batra N, Ho PY, Tu MJ, Yu AM. PMID: 31187211; PMCID: PMC7068804.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    27. A reliable LC-MS/MS method for the quantification of natural amino acids in mouse plasma: Method validation and application to a study on amino acid dynamics during hepatocellular carcinoma progression. J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Aug 15; 1124:72-81. Liu Z, Tu MJ, Zhang C, Jilek JL, Zhang QY, Yu AM. PMID: 31177050; PMCID: PMC6626562.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    28. Novel Synergistic Combination of Mitotic Arrest and Promotion of Apoptosis for Treatment of Pancreatic Adenocarcinoma. Transl Oncol. 2019 Apr; 12(4):683-692. Duan Z, Chinn D, Tu MJ, Zhang QY, Huynh J, Chen J, Mack P, Yu AM, Kim EJ. PMID: 30844579; PMCID: PMC6402293.
      View in: PubMed   Mentions: 10  
    29. Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal Immunogenicity. Mol Ther Nucleic Acids. 2019 Mar 01; 14:498-508. Jilek JL, Zhang QY, Tu MJ, Ho PY, Duan Z, Qiu JX, Yu AM. PMID: 30753993; PMCID: PMC6370598.
      View in: PubMed   Mentions: 27  
    30. Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression. Acta Pharm Sin B. 2019 May; 9(3):639-647. Li X, Tian Y, Tu MJ, Ho PY, Batra N, Yu AM. PMID: 31193825; PMCID: PMC6543075.
      View in: PubMed   Mentions: 38  
    31. RNA therapy: Are we using the right molecules? Pharmacol Ther. 2019 04; 196:91-104. Yu AM, Jian C, Yu AH, Tu MJ. PMID: 30521885; PMCID: PMC6450780.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansAnimals
    32. Co-administration of nuciferine reduces the concentration of metformin in liver via differential inhibition of hepatic drug transporter OCT1 and MATE1. Biopharm Drug Dispos. 2018 Nov; 39(9):411-419. Li L, Lei H, Wang W, Du W, Yuan J, Tu M, Zhou H, Zeng S, Jiang H. PMID: 30294927.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    33. Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models. Cancer Lett. 2019 02 01; 442:82-90. Tu MJ, Ho PY, Zhang QY, Jian C, Qiu JX, Kim EJ, Bold RJ, Gonzalez FJ, Bi H, Yu AM. PMID: 30389433; PMCID: PMC6311422.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    34. Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo. Int J Pharm. 2018 Aug 25; 547(1-2):537-544. Zhang QY, Ho PY, Tu MJ, Jilek JL, Chen QX, Zeng S, Yu AM. PMID: 29894758; PMCID: PMC6388695.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    35. Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy. J Pharmacol Exp Ther. 2018 06; 365(3):494-506. Ho PY, Duan Z, Batra N, Jilek JL, Tu MJ, Qiu JX, Hu Z, Wun T, Lara PN, DeVere White RW, Chen HW, Yu AM. PMID: 29602831; PMCID: PMC5931433.
      View in: PubMed   Mentions: 42     Fields:    Translation:AnimalsCells
    36. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells. Drug Metab Dispos. 2018 01; 46(1):2-10. Li PC, Tu MJ, Ho PY, Jilek JL, Duan Z, Zhang QY, Yu AX, Yu AM. PMID: 29061583; PMCID: PMC5733456.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    37. Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models. Oncotarget. 2017 May 09; 8(19):30742-30755. Jian C, Tu MJ, Ho PY, Duan Z, Zhang Q, Qiu JX, DeVere White RW, Wun T, Lara PN, Lam KS, Yu AX, Yu AM. PMID: 28415566; PMCID: PMC5458164.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    38. Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling. Placenta. 2017 03; 51:57-63. Francois LN, Gorczyca L, Du J, Bircsak KM, Yen E, Wen X, Tu MJ, Yu AM, Illsley NP, Zamudio S, Aleksunes LM. PMID: 28292469; PMCID: PMC5354084.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    39. MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis. Oncotarget. 2016 Jul 19; 7(29):45547-45561. Tu MJ, Pan YZ, Qiu JX, Kim EJ, Yu AM. PMID: 27322206; PMCID: PMC5216741.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    40. Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest. Sci Rep. 2016 05 24; 6:26611. Zhao Y, Tu MJ, Wang WP, Qiu JX, Yu AX, Yu AM. PMID: 27216562; PMCID: PMC4877571.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    41. MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy. Drug Metab Dispos. 2016 Mar; 44(3):308-19. Yu AM, Tian Y, Tu MJ, Ho PY, Jilek JL. PMID: 26566807; PMCID: PMC4767381.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    42. Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth. Biochem Pharmacol. 2015 Dec 15; 98(4):602-13. Zhao Y, Tu MJ, Yu YF, Wang WP, Chen QX, Qiu JX, Yu AX, Yu AM. PMID: 26518752; PMCID: PMC4725324.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    43. [Establishment of MDCK cell models expressing human MATE1 or co-expressing with human OCT1 or OCT2]. Yao Xue Xue Bao. 2015 Jul; 50(7):842-7. Lei HM, Sun SY, Li LP, Tu MJ, Zhou H, Zeng S, Jiang HD. PMID: 26552145.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    44. Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity. Drug Metab Dispos. 2015 Jul; 43(7):1129-36. Li MM, Addepalli B, Tu MJ, Chen QX, Wang WP, Limbach PA, LaSalle JM, Zeng S, Huang M, Yu AM. PMID: 25934574; PMCID: PMC4468437.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    45. Simple and rapid determination of unsaturated fatty acids in 1 µl of rat plasma by LC-MS/MS. Bioanalysis. 2015; 7(9):1081-91. Zheng S, Ma Z, Song F, Ye J, Wang R, Tu M, Li L, Zhou H, Zeng S, Jiang H. PMID: 26039806.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    46. Involvement of organic cation transporter 1 and CYP3A4 in retrorsine-induced toxicity. Toxicology. 2014 Aug 01; 322:34-42. Tu M, Li L, Lei H, Ma Z, Chen Z, Sun S, Xu S, Zhou H, Zeng S, Jiang H. PMID: 24799337.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    47. The contribution of human OCT1, OCT3, and CYP3A4 to nitidine chloride-induced hepatocellular toxicity. Drug Metab Dispos. 2014 Jul; 42(7):1227-34. Li L, Tu M, Yang X, Sun S, Wu X, Zhou H, Zeng S, Jiang H. PMID: 24778366.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    48. Involvement of organic cation transporter 2 inhibition in potential mechanisms of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Aug 04; 53:90-8. Wang K, Sun S, Li L, Tu M, Jiang H. PMID: 24657329.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    49. [In vitro interaction of deferiprone with cellular membrane transporters of hOCTs and hOAT1]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014 03; 43(2):129-34. Kong SS, Tu MJ, Yang X, Hu L, Zhao XS, Zhou H, Zheng S, Jiang HD. PMID: 24782365.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    50. In vitro interaction of clopidogrel and its hydrolysate with OCT1, OCT2 and OAT1. Int J Pharm. 2014 Apr 25; 465(1-2):5-10. Li L, Song F, Tu M, Wang K, Zhao L, Wu X, Zhou H, Xia Z, Jiang H. PMID: 24530383.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    51. Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Mar 03; 49:1-6. Sun S, Wang K, Lei H, Li L, Tu M, Zeng S, Zhou H, Jiang H. PMID: 24246570.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    52. Organic cation transporter 1 mediates the uptake of monocrotaline and plays an important role in its hepatotoxicity. Toxicology. 2013 Sep 15; 311(3):225-30. Tu M, Sun S, Wang K, Peng X, Wang R, Li L, Zeng S, Zhou H, Jiang H. PMID: 23831208.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    53. The exposure of luteolin is much lower than that of apigenin in oral administration of Flos Chrysanthemi extract to rats. Drug Metab Pharmacokinet. 2012; 27(1):162-8. Chen Z, Tu M, Sun S, Kong S, Wang Y, Ye J, Li L, Zeng S, Jiang H. PMID: 21931223.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    Meijuan's Networks
    Concepts (246)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (13)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (59)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California